Supplemental
: Flow cytometry (FCM) monitoring MRD of the T-ALL patient at different time points. CD34, CD71, CD16, CD56 were used as individually MRD monitoring marker of this patient. The percentage of lymphoblasts at various disease states (ND, 117 W, 178W, 190W, 200W and 272W) were shown in the 2D plot figure (CD65 PE and CD16 FITC). Red scatter points represent the lymphoblast in bone marrow. Pink, green, and gray dots represent nucleated erythrocytes, mature lymphocytes and mature granulocytes, respectively, which gated in 2D spot figure (CD45-Percp and Side Scatter-Height).ND, newly diagnose; MRD, minimal residual disease.
